1.
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
by Van Gaal, Luc F
The Lancet (British edition), 2005, Vol.365 (9468), p.1389-1397
2.
Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment: Losartan Intervention for Endpoint Reduction in Hypertension Trial
by Gerdts, Eva
Hypertension (Dallas, Tex. 1979), 2007-02, Vol.49 (2), p.311-316
3.
Hypertension Treatment and Control in Five European Countries, Canada, and the United States
by Wolf-Maier, Katharina
Hypertension (Dallas, Tex. 1979), 2004-01, Vol.43 (1), p.10-17
4.
Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study
by Ibsen, Hans
Hypertension (Dallas, Tex. 1979), 2005-02, Vol.45 (2), p.198-202
5.
High cardiovascular fitness is associated with low metabolic risk score in children : The European youth heart study
by RUIZ, Jonatan R
Pediatric research, 2007, Vol.61 (3), p.350-355
6.
Chronic inflammation in the etiology of disease across the life span
by Furman, David
Nature medicine, 2019-12, Vol.25 (12), p.1822-1832
7.
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiov...
by Danesh, J
European journal of epidemiology, 2007-12-01, Vol.22 (12), p.839-869
8.
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
by Rapsomaniki, Eleni, Dr
The Lancet (British edition), 2014, Vol.383 (9932), p.1899-1911
9.
EPIC-Heart: The cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries
by Danesh, J
European journal of epidemiology, 2007-02-01, Vol.22 (2), p.129-141
10.
Prevention of cardiovascular disease in developing countries
by Lindholm, Lars H
The Lancet (British edition), 2007, Vol.370 (9589), p.720-722
11.
Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study
by Dehghan, Mahshid
The Lancet (British edition), 2017-11-04, Vol.390 (10107), p.2050-2062
12.
Electrocardiographic Strain Pattern and Prediction of Cardiovascular Morbidity and Mortality in Hypertensive Patients
by Okin, Peter M
Hypertension (Dallas, Tex. 1979), 2004-07, Vol.44 (1), p.48-54
13.
HDL and cardiovascular disease
by Rader, Daniel J, Prof
The Lancet (British edition), 2014, Vol.384 (9943), p.618-625
14.
Cardiovascular mortality during heat and cold events: determinants of regional vulnerability in Taiwan
by Wu, Pei-Chih
Occupational and environmental medicine (London, England), 2011-07, Vol.68 (7), p.525-530
15.
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
by Ridker, Paul M, MD
The American heart journal, 2011, Vol.162 (4), p.597-605
16.
Adverse Cardiovascular, Cerebrovascular, and Peripheral Vascular Effects of Marijuana Inhalation: What Cardiologists Need to Know
by Thomas, Grace, MD
The American journal of cardiology, 2014, Vol.113 (1), p.187-190
17.
Vascular disease in a population-based cohort of individuals hospitalised with coeliac disease
by Ludvigsson, J F
Heart (British Cardiac Society), 2007-09, Vol.93 (9), p.1111-1115
18.
The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective
by Mahmood, Syed S, MD
The Lancet (British edition), 2014, Vol.383 (9921), p.999-1008
19.
Pulse Pressure and Effects of Losartan or Atenolol in Patients With Hypertension and Left Ventricular Hypertrophy
by Fyhrquist, Frej
Hypertension (Dallas, Tex. 1979), 2005-04, Vol.45 (4), p.580-585
20.
Triglycerides and cardiovascular disease
by Nordestgaard, Børge G, Prof
The Lancet (British edition), 2014, Vol.384 (9943), p.626-635
